Get ready for next week's stock market action with Seeking Alpha's Catalyst Watch! Discover key events that could impact ...

We remain bullish on PDD despite a 15% share price pullback, viewing it as an attractive entry point for growth-focused ...

Rivian Automotive (NASDAQ:RIVN) investors have failed to shake off the market's anxieties over its growth profile as RIVN's ...

The S&P 500 (SP500) on Friday advanced 1.68% for the week to end at 5,969.34 points, posting gains in four out of five sessions. Its accompanying SPDR S&P 500 ETF Trust (NYSEARCA:SPY) added 1.67% for ...

The third quarter of 2024 brought exciting news. Hili is committed to a 20-year contract with Pan American Energy, thus ...

Raspberry Pi's innovative, low-cost computing devices are gaining traction in industrial and embedded markets, boasting ...

AppLovin trades at a high premium (P/E at 96x), with an EV/EBITDA 180% above the sector median. The e-commerce pilot program ...

The Bottom Line Up Front: SCHD Is Good, But These 2 ETFs Combine Into A 4.5% Yield, 13% to 14% Dividend-Growing Powerhouse.

A 45% forward dividend yield is not “free money.” Income strategy or trading as well, caution is required. MSTY employs ...

The second Formula One Las Vegas Grand Prix takes places on Saturday. The 50-lap evening race will be a pivotal moment in the ...

Chasing yield is like gambling. It can be intoxicating. It can be addictive, And it can be dangerous. Today I will focus on ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...